Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00897819
What this trial is testing

Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200

Who this might be right for
Colorectal Cancer
ECOG-ACRIN Cancer Research Group 350
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Not applicableStudy completedNCT00737230
What this trial is testing

Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis

Who this might be right for
Cancer
Royal Marsden NHS Foundation Trust 250
Not applicableStudy completedNCT00004891
What this trial is testing

PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 149
Early research (Phase 1)Study completedNCT00019773
What this trial is testing

Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

Who this might be right for
Carcinoma of the AppendixColorectal CancerSmall Intestine Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00559741
What this trial is testing

Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Institut Cancerologie de l'Ouest 80
Early research (Phase 1)Ended earlyNCT01126450
What this trial is testing

Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)WithdrawnNCT05356897
What this trial is testing

Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Rectal Adenocarcinoma+3 more
Academic and Community Cancer Research United
Not applicableActive Not RecruitingNCT04224779
What this trial is testing

Liquid Biopsies and IMAging for Improved Cancer Care

Who this might be right for
Rectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 16
Early research (Phase 1)Active Not RecruitingNCT04046445
What this trial is testing

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal CancerMSSStage IV Colon Cancer+3 more
Amal Therapeutics 96
Testing effectiveness (Phase 2)Study completedNCT00052507
What this trial is testing

Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT01471353
What this trial is testing

Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
University of Florida 43
Early research (Phase 1)Ended earlyNCT04873895
What this trial is testing

TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)

Who this might be right for
Colorectal Neoplasms Malignant
Abramson Cancer Center at Penn Medicine 5
Not applicableActive Not RecruitingNCT05524012
What this trial is testing

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapy+1 more
Jena University Hospital 40
Early research (Phase 1)Study completedNCT00003360
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 24
Not applicableStudy completedNCT00478010
What this trial is testing

Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer

Who this might be right for
Colorectal CancerPancreatic CancerPsychosocial Effects of Cancer and Its Treatment
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 205
Testing effectiveness (Phase 2)WithdrawnNCT00003786
What this trial is testing

Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Not applicableNot Yet RecruitingNCT07552207
What this trial is testing

Comparison of [68Ga]Ga-CTR-FAPI and 18F-FDG PET/MRI for Lymph Node Staging in Rectal Cancer

Who this might be right for
Rectal CancerLymph Node MetastasesPET / MR
Peking University Cancer Hospital & Institute 30
Next Page